» Articles » PMID: 38107795

Osteoporosis and Obesity

Overview
Journal Indian J Orthop
Publisher Springer Nature
Specialty Orthopedics
Date 2023 Dec 18
PMID 38107795
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: This article concisely overviews the complex relationship between obesity and bone health. Obesity, characterized by excessive fat accumulation, has been traditionally associated with higher bone mineral density. Also, recent data suggest a favorable bone microarchitecture profile in these patients. However, the increase in bone mineral density does not necessarily confer protection against fractures, and the risk of fractures may vary depending on the skeletal sites.

Factors Affecting Bone Health: Various factors, including mechanical factors, hormones, cytokines, inflammation, and bone marrow adiposity, contribute to the adverse effect of obesity on bone. The article explores these factors alongside non-invasive techniques and tools like the Fracture Risk Assessment (FRAX) to evaluate fracture risk.

Bone And Adipose Tissue: This article also highlights the essential roles of hormones such as vitamin D, Parathormone (PTH), FGF-23 (Fibroblast Growth Factor 23), which affect bone health, and some of the hormones secreted from the adipose tissues such as adiponectin and leptin.

Obesity Paradox And Sarcopenic Obesity: The article delves into the intriguing obesity paradox, where an increased BMI correlates with higher bone mineral density but not necessarily reduced fracture risk. Sarcopenic obesity, a combination of excessive fat accumulation and reduced muscle mass, further complicates the relationship between obesity and bone health.

Conclusions: Physicians should keep a comprehensive approach to treating obese patients with osteoporosis, including lifestyle modifications, weight management, fall prevention strategies, and pharmacological interventions. Further research is needed to better understand the relationship between obesity and bone health.

Citing Articles

Association between systemic immune-inflammation index and trimethylamine N-oxide levels in peripheral blood and osteoporosis in overweight and obese patients.

Li L, An J, Bai J, Zhang Y, Li X, Lv H Front Endocrinol (Lausanne). 2025; 16:1539594.

PMID: 40017693 PMC: 11864960. DOI: 10.3389/fendo.2025.1539594.


A Study on the Prevalence of Osteoporosis in People with Different Altitudes in Sichuan, China.

Yang R, Ma Q, Zhang X, Zhao Q, Zeng S, Yan H Clin Interv Aging. 2024; 19:1819-1828.

PMID: 39525876 PMC: 11549880. DOI: 10.2147/CIA.S478020.


Links among Obesity, Type 2 Diabetes Mellitus, and Osteoporosis: Bone as a Target.

Martiniakova M, Biro R, Penzes N, Sarocka A, Kovacova V, Mondockova V Int J Mol Sci. 2024; 25(9).

PMID: 38732046 PMC: 11084398. DOI: 10.3390/ijms25094827.

References
1.
Ruhl C, Everhart J . Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res. 2002; 17(10):1896-903. DOI: 10.1359/jbmr.2002.17.10.1896. View

2.
Tang X, Liu G, Kang J, Hou Y, Jiang F, Yuan W . Obesity and risk of hip fracture in adults: a meta-analysis of prospective cohort studies. PLoS One. 2013; 8(4):e55077. PMC: 3625172. DOI: 10.1371/journal.pone.0055077. View

3.
Tu Q, Zhang J, Dong L, Saunders E, Luo E, Tang J . Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem. 2011; 286(14):12542-53. PMC: 3069456. DOI: 10.1074/jbc.M110.152405. View

4.
Grace C, Vincent R, Aylwin S . High prevalence of vitamin D insufficiency in a United Kingdom urban morbidly obese population: implications for testing and treatment. Surg Obes Relat Dis. 2014; 10(2):355-60. DOI: 10.1016/j.soard.2013.07.017. View

5.
Conde J, Scotece M, Gomez R, Lopez V, Gomez-Reino J, Gualillo O . Adipokines and osteoarthritis: novel molecules involved in the pathogenesis and progression of disease. Arthritis. 2011; 2011:203901. PMC: 3200120. DOI: 10.1155/2011/203901. View